Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation
暂无分享,去创建一个
D. Henrion | P. Bigey | V. Escriou | C. Chaussain | D. Smadja | B. Dizier | V. Nivet-Antoine | C. Boisson-Vidal | J. Sadoine | V. Mignon | E. Vessières | A. Domingues | P. Marquet de Rougé | C. Boisson‐Vidal